People · Operator
Named in public records as an officer, director or promoter · active 2013–2022 · Healthtech, Other Health Care, Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RefleXion Medical, Inc. | — | Healthtech | Series D+ | $413.0M | $1.3B | 2022 |
| NeuroPace Inc | — | Other Health Care | Series C | $208.6M | $1.5B | 2013 |
| Cala Health, Inc. | — | Healthtech | Series C | $166.1M | $369.8M | 2016 |
| Osteal Therapeutics, Inc. | — | Pharmaceuticals | Series C | $127.5M | $87.0M | 2018 |
| Tusker Medical, Inc. | — | Biotechnology | Series B | $53.5M | $79.4M | 2016 |
| Hyalex Orthopaedics, Inc. | — | Other Health Care | Series B | $30.4M | $91.1M | 2017 |
Renee Ryan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Renee Ryan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nael Kassar | 2 | 11 |
| Greg Garfield | 2 | 8 |
| Brad Vale | 2 | 4 |
| Seth Harrison | 1 | 19 |
| Wende Hutton | 1 | 16 |
| Rishi Gupta | 1 | 12 |
| Jonathan Silverstein | 1 | 10 |
| David Thompson | 1 | 10 |
| Amir Abolfathi | 1 | 8 |
| James Blair | 1 | 8 |
| FRED MOLL | 1 | 8 |
| Michael Carusi | 1 | 7 |
| Michael A. Carusi | 1 | 6 |
| Jay Watkins | 1 | 6 |
| David Fischell | 1 | 6 |
| ANTOINE PAPIERNIK | 1 | 6 |
| John Kuelper | 1 | 6 |
| Sami Hamade | 1 | 6 |
| Frank Fischer | 1 | 5 |
| William Burkoth | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.